Patent details
EP2935303
Title:
4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV
Basic Information
- Publication number:
- EP2935303
- PCT Application Number:
- US2013076740
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP138644034
- PCT Publication Number:
- WO2014100505
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV
- French Title of Invention:
- 4'-FLUORO-NUCLÉOSIDES, 4'-FLUORO-NUCLÉOTIDES ET LEURS ANALOGUES POUR LE TRAITEMENT DU VHC
- German Title of Invention:
- 4'-FLUOR-NUKLEOSIDE, 4'-FLUOR-NUKLEOTIDE UND ANALOGA DAVON ZUR BEHANDLUNG VON HCV
- SPC Number:
-
Dates
- Filing date:
- 19/12/2013
- Grant date:
- 17/02/2021
- EP Publication Date:
- 28/10/2015
- PCT Publication Date:
- 26/06/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/02/2021
- EP B1 Publication Date:
- 17/02/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/12/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/02/2021
-
-
- Name:
- Janssen BioPharma, Inc.
- Address:
- 260 E. Grand Ave., 2nd Floor, South San Francisco, CA 94080, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 30/03/2021
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BEIGELMAN, Leonid
- Address:
- United States (US)
2
- Name:
- WANG, Guangyi
- Address:
- United States (US)
3
- Name:
- SMITH, David, Bernard
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261745466 P
- Priority Date:
- 21/12/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361890125 P
- Priority Date:
- 11/10/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/7068;
A61K 31/7072;
A61K 31/7076;
A61K 31/708;
A61P 31/14;
C07H 19/067;
C07H 19/073;
C07H 19/10;
C07H 19/167;
C07H 19/173;
C07H 19/20;
C07H 19/213;
Publication
European Patent Bulletin
- Issue number:
- 202107
- Publication date:
- 17/02/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 13
- Annual Fee Amount:
- 180 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 13/12/2024
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 165 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM